The global amniotic membrane market is estimated to be valued at US$ 3.62 billion in 2023 and is expected to exhibit a CAGR of 13% during the forecast period (2023-2030).
Market- Trends
Increasing Product Launches by the Market Players
On July 26, 2022, Eliksa Therapeutics, a regenerative medicine company, aimed to commercialize multiple regenerative therapeutics based on amniotic fluid and amniotic membrane technologies.
Increasing Research and Development Activities by the Market Players
On September 16, 2022, Théa Pharma Inc., an independent pharmaceutical company, showcased AcellFX, an acellular amniotic membrane, at Vision Expo West.
Global Amniotic Membrane Market – Forecast Period, Trends
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients